{"metadata":{"kernelspec":{"name":"python3","display_name":"Python 3","language":"python"},"language_info":{"name":"python","version":"3.11.13","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[],"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"markdown","source":"##### Copyright 2025 Google LLC.","metadata":{}},{"cell_type":"code","source":"# @title Licensed under the Apache License, Version 2.0 (the \"License\");\n# you may not use this file except in compliance with the License.\n# You may obtain a copy of the License at\n#\n# https://www.apache.org/licenses/LICENSE-2.0\n#\n# Unless required by applicable law or agreed to in writing, software\n# distributed under the License is distributed on an \"AS IS\" BASIS,\n# WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.\n# See the License for the specific language governing permissions and\n# limitations under the License.","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:20:01.345278Z","iopub.execute_input":"2025-11-14T05:20:01.345603Z","iopub.status.idle":"2025-11-14T05:20:01.350483Z","shell.execute_reply.started":"2025-11-14T05:20:01.345582Z","shell.execute_reply":"2025-11-14T05:20:01.349593Z"}},"outputs":[],"execution_count":1},{"cell_type":"markdown","source":"# üöÄ Memory Management - Part 1 - Sessions\n\n**Welcome to Day 3 of the Kaggle 5-day Agents course!**\n\nIn this notebook, you'll learn:\n\n- ‚úÖ What sessions are and how to use them in your agent\n- ‚úÖ How to build *stateful* agents with sessions and events\n- ‚úÖ How to persist sessions in a database\n- ‚úÖ Context management practices such as context compaction\n- ‚úÖ Best practices for sharing session State","metadata":{}},{"cell_type":"markdown","source":"## ‚ÄºÔ∏è Please Read\n\n\n> ‚ùå **‚ÑπÔ∏è Note: No submission required!**\n> This notebook is for your hands-on practice and learning only. You **do not** need to submit it anywhere to complete the course.\n\n> ‚è∏Ô∏è **Note:**  When you first start the notebook via running a cell you might see a banner in the notebook header that reads **\"Waiting for the next available notebook\"**. The queue should drop rapidly; however, during peak bursts you might have to wait a few minutes.\n\n> ‚ùå **Note:** Avoid using the **Run all** cells command as this can trigger a QPM limit resulting in 429 errors when calling the backing model. Suggested flow is to run each cell in order - one at a time. [See FAQ on 429 errors for more information.](https://www.kaggle.com/code/kaggle5daysofai/day-0-troubleshooting-and-faqs)\n\n**For help: Ask questions on the [Kaggle Discord](https://discord.com/invite/kaggle) server.**","metadata":{}},{"cell_type":"markdown","source":"## üìñ Get started with Kaggle Notebooks\n\nIf this is your first time using Kaggle Notebooks, welcome! You can learn more about using Kaggle Notebooks [in the documentation](https://www.kaggle.com/docs/notebooks).\n\nHere's how to get started:\n\n**1. Verify Your Account (Required)**\n\nTo use the Kaggle Notebooks in this course, you'll need to verify your account with a phone number.\n\nYou can do this in your [Kaggle settings](https://www.kaggle.com/settings).\n\n**2. Make Your Own Copy**\n\nTo run any code in this notebook, you first need your own editable copy.\n\nClick the `Copy and Edit` button in the top-right corner.\n\n![Copy and Edit button](https://storage.googleapis.com/kaggle-media/Images/5gdai_sc_1.png)\n\nThis creates a private copy of the notebook just for you.\n\n**3. Run Code Cells**\n\nOnce you have your copy, you can run code.\n\nClick the ‚ñ∂Ô∏è Run button next to any code cell to execute it.\n\n![Run cell button](https://storage.googleapis.com/kaggle-media/Images/5gdai_sc_2.png)\n\nRun the cells in order from top to bottom.\n\n**4. If You Get Stuck**\n\nTo restart: Select `Factory reset` from the `Run` menu.\n\nFor help: Ask questions on the [Kaggle Discord](https://discord.com/invite/kaggle) server.","metadata":{"jp-MarkdownHeadingCollapsed":true}},{"cell_type":"markdown","source":"---\n## ‚öôÔ∏è Section 1: Setup\n\n### 1.1: Install dependencies\n\nThe Kaggle Notebooks environment includes a pre-installed version of the [google-adk](https://google.github.io/adk-docs/) library for Python and its required dependencies, so you don't need to install additional packages in this notebook.\n\nTo install and use ADK in your own Python development environment outside of this course, you can do so by running:\n\n```\npip install google-adk\n```","metadata":{}},{"cell_type":"markdown","source":"### 1.2: Configure your Gemini API Key\n\nThis notebook uses the [Gemini API](https://ai.google.dev/gemini-api/docs), which requires authentication.\n\n**1. Get your API key**\n\nIf you don't have one already, create an [API key in Google AI Studio](https://aistudio.google.com/app/api-keys).\n\n**2. Add the key to Kaggle Secrets**\n\nNext, you will need to add your API key to your Kaggle Notebook as a Kaggle User Secret.\n\n1. In the top menu bar of the notebook editor, select `Add-ons` then `Secrets`.\n2. Create a new secret with the label `GOOGLE_API_KEY`.\n3. Paste your API key into the \"Value\" field and click \"Save\".\n4. Ensure that the checkbox next to `GOOGLE_API_KEY` is selected so that the secret is attached to the notebook.\n\n**3. Authenticate in the notebook**\n\nRun the cell below to complete authentication.","metadata":{}},{"cell_type":"code","source":"import os\nfrom kaggle_secrets import UserSecretsClient\n\ntry:\n    GOOGLE_API_KEY = UserSecretsClient().get_secret(\"GOOGLE_API_KEY\")\n    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n    print(\"‚úÖ Gemini API key setup complete.\")\nexcept Exception as e:\n    print(\n        f\"üîë Authentication Error: Please make sure you have added 'GOOGLE_API_KEY' to your Kaggle secrets. Details: {e}\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:20:29.549426Z","iopub.execute_input":"2025-11-14T05:20:29.550244Z","iopub.status.idle":"2025-11-14T05:20:29.654680Z","shell.execute_reply.started":"2025-11-14T05:20:29.550216Z","shell.execute_reply":"2025-11-14T05:20:29.653744Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Gemini API key setup complete.\n","output_type":"stream"}],"execution_count":2},{"cell_type":"markdown","source":"### 1.3: Import ADK components\n\nNow, import the specific components you'll need from the Agent Development Kit and the Generative AI library. This keeps your code organized and ensures we have access to the necessary building blocks.","metadata":{}},{"cell_type":"code","source":"from typing import Any, Dict\n\nfrom google.adk.agents import Agent, LlmAgent\nfrom google.adk.apps.app import App, EventsCompactionConfig\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.sessions import DatabaseSessionService\nfrom google.adk.sessions import InMemorySessionService\nfrom google.adk.runners import Runner\nfrom google.adk.tools.tool_context import ToolContext\nfrom google.genai import types\n\nprint(\"‚úÖ ADK components imported successfully.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:20:33.784170Z","iopub.execute_input":"2025-11-14T05:20:33.784490Z","iopub.status.idle":"2025-11-14T05:21:16.153250Z","shell.execute_reply.started":"2025-11-14T05:20:33.784466Z","shell.execute_reply":"2025-11-14T05:21:16.152308Z"}},"outputs":[{"name":"stdout","text":"‚úÖ ADK components imported successfully.\n","output_type":"stream"}],"execution_count":3},{"cell_type":"markdown","source":"### 1.4: Helper functions\n\nHelper function that manages a complete conversation session, handling session\ncreation/retrieval, query processing, and response streaming. It supports\nboth single queries and multiple queries in sequence.\n\nExample:\n\n```\n>>> await run_session(runner, \"What is the capital of France?\", \"geography-session\")\n>>> await run_session(runner, [\"Hello!\", \"What's my name?\"], \"user-intro-session\")\n```","metadata":{}},{"cell_type":"code","source":"# Define helper functions that will be reused throughout the notebook\nasync def run_session(\n    runner_instance: Runner,\n    user_queries: list[str] | str = None,\n    session_name: str = \"default\",\n):\n    print(f\"\\n ### Session: {session_name}\")\n\n    # Get app name from the Runner\n    app_name = runner_instance.app_name\n\n    # Attempt to create a new session or retrieve an existing one\n    try:\n        session = await session_service.create_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n    except:\n        session = await session_service.get_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n\n    # Process queries if provided\n    if user_queries:\n        # Convert single query to list for uniform processing\n        if type(user_queries) == str:\n            user_queries = [user_queries]\n\n        # Process each query in the list sequentially\n        for query in user_queries:\n            print(f\"\\nUser > {query}\")\n\n            # Convert the query string to the ADK Content format\n            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n\n            # Stream the agent's response asynchronously\n            async for event in runner_instance.run_async(\n                user_id=USER_ID, session_id=session.id, new_message=query\n            ):\n                # Check if the event contains valid content\n                if event.content and event.content.parts:\n                    # Filter out empty or \"None\" responses before printing\n                    if (\n                        event.content.parts[0].text != \"None\"\n                        and event.content.parts[0].text\n                    ):\n                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n    else:\n        print(\"No queries!\")\n\n\nprint(\"‚úÖ Helper functions defined.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:22:38.096447Z","iopub.execute_input":"2025-11-14T05:22:38.098281Z","iopub.status.idle":"2025-11-14T05:22:38.106606Z","shell.execute_reply.started":"2025-11-14T05:22:38.098251Z","shell.execute_reply":"2025-11-14T05:22:38.105855Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Helper functions defined.\n","output_type":"stream"}],"execution_count":4},{"cell_type":"markdown","source":"### 1.5: Configure Retry Options\n\nWhen working with LLMs, you may encounter transient errors like rate limits or temporary service unavailability. Retry options automatically handle these failures by retrying the request with exponential backoff.","metadata":{}},{"cell_type":"code","source":"retry_config = types.HttpRetryOptions(\n    attempts=5,  # Maximum retry attempts\n    exp_base=7,  # Delay multiplier\n    initial_delay=1,\n    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:22:52.945008Z","iopub.execute_input":"2025-11-14T05:22:52.945582Z","iopub.status.idle":"2025-11-14T05:22:52.950227Z","shell.execute_reply.started":"2025-11-14T05:22:52.945557Z","shell.execute_reply":"2025-11-14T05:22:52.949144Z"}},"outputs":[],"execution_count":5},{"cell_type":"markdown","source":"---\n## ü§π Section 2: Session Management\n\n### 2.1 The Problem\n\nAt their core, Large Language Models are **inherently stateless**. Their awareness is confined to the information you provide in a single API call. This means an agent without proper context management will react to the current prompt without considering any previous history.\n\n**‚ùì Why does this matter?** Imagine trying to have a meaningful conversation with someone who forgets everything you've said after each sentence. That's the challenge we face with raw LLMs!\n\nIn ADK, we use `Sessions` for **short term memory management** and `Memory` for **long term memory.** In the next notebook, you'll focus on `Memory`.","metadata":{}},{"cell_type":"markdown","source":"### 2.2 What is a Session?\n\n#### **üì¶ Session**\n\nA session is a container for conversations. It encapsulates the conversation history in a chronological manner and also records all tool interactions and responses for a **single, continuous conversation**. A session is tied to a user and agent; it is not shared with other users. Similarly, a session history for an Agent is not shared with other Agents.\n\nIn ADK, a **Session** is comprised of two key components `Events` and `State`:\n\n**üìù Session.Events**:\n\n> While a session is a container for conversations, `Events` are the building blocks of a conversation.\n>\n> Example of Events:\n> - *User Input*: A message from the user (text, audio, image, etc.)\n> - *Agent Response*: The agent's reply to the user\n> - *Tool Call*: The agent's decision to use an external tool or API\n> - *Tool Output*: The data returned from a tool call, which the agent uses to continue its reasoning\n    \n\n**{} Session.State**:\n\n> `session.state` is the Agent's scratchpad, where it stores and updates dynamic details needed during the conversation. Think of it as a global `{key, value}` pair storage which is available to all subagents and tools.","metadata":{}},{"cell_type":"markdown","source":"<img src=\"https://storage.googleapis.com/github-repo/kaggle-5days-ai/day3/session-state-and-events.png\" width=\"320\" alt=\"Session state and events\">\n\n<!-- ```mermaid\ngraph TD\n    subgraph A[\"Agentic Application\"];\n        subgraph U[\"User\"]\n            subgraph S1[\"Session\"]\n                D1[\"Session.Events\"]\n                D2[\"Session.State\"]\n            end\n        end\n    end\n``` -->","metadata":{}},{"cell_type":"markdown","source":"### 2.3 How to manage sessions?\n\nAn agentic application can have multiple users and each user may have multiple sessions with the application.\nTo manage these sessions and events, ADK offers a **Session Manager** and **Runner**.\n\n1. **`SessionService`**: The storage layer\n   - Manages creation, storage, and retrieval of session data\n   - Different implementations for different needs (memory, database, cloud)\n\n2. **`Runner`**: The orchestration layer\n   - Manages the flow of information between user and agent\n   - Automatically maintains conversation history\n   - Handles the Context Engineering behind the scenes\n\nThink of it like this:\n\n- **Session** = A notebook üìì\n- **Events** = Individual entries in a single page üìù\n- **SessionService** = The filing cabinet storing notebooks üóÑÔ∏è\n- **Runner** = The assistant managing the conversation ü§ñ","metadata":{}},{"cell_type":"markdown","source":"### 2.4 Implementing Our First Stateful Agent\n\nLet's build our first stateful agent, that can remember and have constructive conversations. \n\nADK offers different types of sessions suitable for different needs. As a start, we'll start with a simple Session Management option (`InMemorySessionService`):","metadata":{}},{"cell_type":"code","source":"APP_NAME = \"default\"  # Application\nUSER_ID = \"default\"  # User\nSESSION = \"default\"  # Session\n\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n\n# Step 1: Create the LLM Agent\nroot_agent = Agent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot\",  # Description of the agent's purpose\n)\n\n# Step 2: Set up Session Management\n# InMemorySessionService stores conversations in RAM (temporary)\nsession_service = InMemorySessionService()\n\n# Step 3: Create the Runner\nrunner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"‚úÖ Stateful agent initialized!\")\nprint(f\"   - Application: {APP_NAME}\")\nprint(f\"   - User: {USER_ID}\")\nprint(f\"   - Using: {session_service.__class__.__name__}\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:49:36.026679Z","iopub.execute_input":"2025-11-14T05:49:36.028526Z","iopub.status.idle":"2025-11-14T05:49:36.038064Z","shell.execute_reply.started":"2025-11-14T05:49:36.028494Z","shell.execute_reply":"2025-11-14T05:49:36.036960Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Stateful agent initialized!\n   - Application: default\n   - User: default\n   - Using: InMemorySessionService\n","output_type":"stream"}],"execution_count":6},{"cell_type":"markdown","source":"### 2.5 Testing Our Stateful Agent\n\nNow let's see the magic of sessions in action!","metadata":{}},{"cell_type":"code","source":"# Run a conversation with two queries in the same session\n# Notice: Both queries are part of the SAME session, so context is maintained\nawait run_session(\n    runner,\n    [\n        \"Hi, I am Sam! What is the capital of United States?\",\n        \"Hello! What is my name?\",  # This time, the agent should remember!\n    ],\n    \"stateful-agentic-session\",\n)","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:50:11.764842Z","iopub.execute_input":"2025-11-14T05:50:11.765680Z","iopub.status.idle":"2025-11-14T05:50:13.204526Z","shell.execute_reply.started":"2025-11-14T05:50:11.765656Z","shell.execute_reply":"2025-11-14T05:50:13.203673Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > Hi, I am Sam! What is the capital of United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  You told me your name is Sam.\n","output_type":"stream"}],"execution_count":7},{"cell_type":"markdown","source":"üéâ **Success!** The agent remembered your name because both queries were part of the same session. The Runner automatically maintained the conversation history.\n\nBut there's a catch: `InMemorySessionService` is temporary. **Once the application stops, all conversation history is lost.** \n","metadata":{}},{"cell_type":"markdown","source":"### üõë (Optional) 2.6 Testing Agent's forgetfulness\n\n> To verify that the agent forgets the conversation, **restart the kernel**. Then, **run ALL the previous cells in this notebook EXCEPT the `run_session` in 2.5.**\n> \n> Now run the cell below. You'll see that the agent doesn't remember anything from the previous conversation.","metadata":{}},{"cell_type":"code","source":"# Run this cell after restarting the kernel. All this history will be gone...\nawait run_session(\n    runner,\n    [\"What did I ask you about earlier?\", \"And remind me, what's my name?\"],\n    \"stateful-agentic-session\",\n)  # Note, we are using same session name","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:50:53.210181Z","iopub.execute_input":"2025-11-14T05:50:53.210529Z","iopub.status.idle":"2025-11-14T05:50:54.280815Z","shell.execute_reply.started":"2025-11-14T05:50:53.210503Z","shell.execute_reply":"2025-11-14T05:50:54.279926Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > What did I ask you about earlier?\ngemini-2.5-flash-lite >  Earlier, you asked me what the capital of the United States is.\n\nUser > And remind me, what's my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":8},{"cell_type":"markdown","source":"### The Problem\n\nSession information is not persistent (i.e., meaningful conversations are lost). While this is advantageous in testing environments, **in the real world, a user should be able to refer from past and resume conversations.** To achieve this, we must persist information. ","metadata":{}},{"cell_type":"markdown","source":"---\n## üìà Section 3: Persistent Sessions with `DatabaseSessionService`\n\nWhile `InMemorySessionService` is great for prototyping, real-world applications need conversations to survive restarts, crashes, and deployments. Let's level up to persistent storage!\n\n### 3.1 Choosing the Right SessionService\n\nADK provides different SessionService implementations for different needs:\n\n| Service | Use Case | Persistence | Best For |\n|---------|----------|-------------|----------|\n| **InMemorySessionService** | Development & Testing | ‚ùå Lost on restart | Quick prototypes |\n| **DatabaseSessionService** | Self-managed apps | ‚úÖ Survives restarts | Small to medium apps |\n| **Agent Engine Sessions** | Production on GCP | ‚úÖ Fully managed | Enterprise scale |\n","metadata":{}},{"cell_type":"markdown","source":"### 3.2 Implementing Persistent Sessions\n\nLet's upgrade to `DatabaseSessionService` using SQLite. This gives us persistence without needing a separate database server for this demo.\n\nLet's create a `chatbot_agent` capable of having a conversation with the user.","metadata":{}},{"cell_type":"code","source":"# Step 1: Create the same agent (notice we use LlmAgent this time)\nchatbot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot with persistent memory\",\n)\n\n# Step 2: Switch to DatabaseSessionService\n# SQLite database will be created automatically\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Step 3: Create a new runner with persistent storage\nrunner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"‚úÖ Upgraded to persistent sessions!\")\nprint(f\"   - Database: my_agent_data.db\")\nprint(f\"   - Sessions will survive restarts!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:53:15.710053Z","iopub.execute_input":"2025-11-14T05:53:15.710947Z","iopub.status.idle":"2025-11-14T05:53:15.813949Z","shell.execute_reply.started":"2025-11-14T05:53:15.710913Z","shell.execute_reply":"2025-11-14T05:53:15.813118Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Upgraded to persistent sessions!\n   - Database: my_agent_data.db\n   - Sessions will survive restarts!\n","output_type":"stream"}],"execution_count":9},{"cell_type":"markdown","source":"### 3.3 Test Run 1: Verifying Persistence\n\nIn this first test run, we'll start a new conversation with the session ID `test-db-session-01`. We will first introduce our name as 'Sam' and then ask a question. In the second turn, we will ask the agent for our name.\n\nSince we are using `DatabaseSessionService`, the agent should remember the name.\n\nAfter the conversation, we'll inspect the `my_agent_data.db` SQLite database directly to see how the conversation `events` (the user queries and model responses) are stored.\n","metadata":{}},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:54:28.690049Z","iopub.execute_input":"2025-11-14T05:54:28.690897Z","iopub.status.idle":"2025-11-14T05:54:29.959636Z","shell.execute_reply.started":"2025-11-14T05:54:28.690852Z","shell.execute_reply":"2025-11-14T05:54:29.958928Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > Hi, I am Sam! What is the capital of the United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":10},{"cell_type":"markdown","source":"### üõë (Optional) 3.4 Test Run 2: Resuming a Conversation\n\n> ‚ÄºÔ∏è Now, let's repeat the test again, but this time, **let's stop this Kaggle Notebook's kernel and restart it again.**\n>\n> 1. Run all the previous cells in the notebook, **EXCEPT** the previous Section 3.3 (`run_session` cell).\n>\n> 2. Now, run the below cell with the **same session ID** (`test-db-session-01`).\n\nWe will ask a new question and then ask for our name again. **Because the session is loaded from the database, the agent should still remember** that our name is 'Sam' from the first test run. This demonstrates the power of persistent sessions.\n","metadata":{}},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:55:09.450555Z","iopub.execute_input":"2025-11-14T05:55:09.450903Z","iopub.status.idle":"2025-11-14T05:55:10.512609Z","shell.execute_reply.started":"2025-11-14T05:55:09.450863Z","shell.execute_reply":"2025-11-14T05:55:10.511709Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > What is the capital of India?\ngemini-2.5-flash-lite >  The capital of India is New Delhi.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":11},{"cell_type":"markdown","source":"### 3.5 Let's verify that the session data is isolated\n\nAs mentioned earlier, a session is private conversation between an Agent and a User (i.e., two sessions do not share information). Let's run our `run_session` with a different session name `test-db-session-02` to confirm this.\n","metadata":{}},{"cell_type":"code","source":"await run_session(\n    runner, [\"Hello! What is my name?\"], \"test-db-session-02\"\n)  # Note, we are using new session name","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:55:40.784830Z","iopub.execute_input":"2025-11-14T05:55:40.785159Z","iopub.status.idle":"2025-11-14T05:55:41.537737Z","shell.execute_reply.started":"2025-11-14T05:55:40.785138Z","shell.execute_reply":"2025-11-14T05:55:41.536851Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-02\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  I do not have access to your personal information, including your name. I am a large language model, and I am not able to store or retrieve personal data.\n","output_type":"stream"}],"execution_count":12},{"cell_type":"markdown","source":"### 3.6 How are the events stored in the Database?\n\nSince we are using a sqlite DB to store information, let's have a quick peek to see how information is stored.","metadata":{}},{"cell_type":"code","source":"import sqlite3\n\ndef check_data_in_db():\n    with sqlite3.connect(\"my_agent_data.db\") as connection:\n        cursor = connection.cursor()\n        result = cursor.execute(\n            \"select app_name, session_id, author, content from events\"\n        )\n        print([_[0] for _ in result.description])\n        for each in result.fetchall():\n            print(each)\n\n\ncheck_data_in_db()","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:56:02.699583Z","iopub.execute_input":"2025-11-14T05:56:02.699939Z","iopub.status.idle":"2025-11-14T05:56:02.706489Z","shell.execute_reply.started":"2025-11-14T05:56:02.699912Z","shell.execute_reply":"2025-11-14T05:56:02.705612Z"}},"outputs":[{"name":"stdout","text":"['app_name', 'session_id', 'author', 'content']\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. I am a large language model, and I am not able to store or retrieve personal data.\"}], \"role\": \"model\"}')\n","output_type":"stream"}],"execution_count":13},{"cell_type":"markdown","source":"---\n## ‚è≥ Section 4: Context Compaction\n\nAs you can see, all the events are stored in full in the session Database, and this quickly adds up. For a long, complex task, this list of events can become very large, leading to slower performance and higher costs.\n\nBut what if we could automatically summarize the past? Let's use ADK's **Context Compaction** feature to see **how to automatically reduce the context that's stored in the Session.**","metadata":{}},{"cell_type":"markdown","source":"<img src=\"https://storage.googleapis.com/github-repo/kaggle-5days-ai/day3/context-compaction.png\" width=\"1400\" alt=\"Context compaction\">","metadata":{}},{"cell_type":"markdown","source":"### 4.1 Create an App for the agent\n\nTo enable this feature, let's use the same `chatbot_agent` we created in Section 3.2. \n\nThe first step is to create an object called `App`. We'll give it a name and pass in our chatbot_agent. \n\nWe'll also create a new config to do the Context Compaction. This **`EventsCompactionConfig`** defines two key variables:\n\n- **compaction_interval**: Asks the Runner to compact the history after every `n` conversations\n- **overlap_size**: Defines the number of previous conversations to retain for overlap\n\nWe'll then provide this app to the Runner.\n","metadata":{}},{"cell_type":"code","source":"# Re-define our app with Events Compaction enabled\nresearch_app_compacting = App(\n    name=\"research_app_compacting\",\n    root_agent=chatbot_agent,\n    # This is the new part!\n    events_compaction_config=EventsCompactionConfig(\n        compaction_interval=3,  # Trigger compaction every 3 invocations\n        overlap_size=1,  # Keep 1 previous turn for context\n    ),\n)\n\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Create a new runner for our upgraded app\nresearch_runner_compacting = Runner(\n    app=research_app_compacting, session_service=session_service\n)\n\n\nprint(\"‚úÖ Research App upgraded with Events Compaction!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T05:59:53.655458Z","iopub.execute_input":"2025-11-14T05:59:53.656186Z","iopub.status.idle":"2025-11-14T05:59:53.665682Z","shell.execute_reply.started":"2025-11-14T05:59:53.656157Z","shell.execute_reply":"2025-11-14T05:59:53.664854Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Research App upgraded with Events Compaction!\n","output_type":"stream"},{"name":"stderr","text":"/tmp/ipykernel_48/3773147741.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n  events_compaction_config=EventsCompactionConfig(\n","output_type":"stream"}],"execution_count":14},{"cell_type":"markdown","source":"### 4.2 Running the Demo\n\nNow, let's have a conversation that is long enough to trigger the compaction. When you run the cell below, the output will look like a normal conversation. However, because we configured our `App`, a compaction process will run silently in the background after the 3rd invocation.\n\nIn the next step, we'll prove that it happened.","metadata":{}},{"cell_type":"code","source":"# Turn 1\nawait run_session(\n    research_runner_compacting,\n    \"What is the latest news about AI in healthcare?\",\n    \"compaction_demo\",\n)\n\n# Turn 2\nawait run_session(\n    research_runner_compacting,\n    \"Are there any new developments in drug discovery?\",\n    \"compaction_demo\",\n)\n\n# Turn 3 - Compaction should trigger after this turn!\nawait run_session(\n    research_runner_compacting,\n    \"Tell me more about the second development you found.\",\n    \"compaction_demo\",\n)\n\n# Turn 4\nawait run_session(\n    research_runner_compacting,\n    \"Who are the main companies involved in that?\",\n    \"compaction_demo\",\n)","metadata":{"scrolled":true,"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T06:00:27.325282Z","iopub.execute_input":"2025-11-14T06:00:27.325588Z","iopub.status.idle":"2025-11-14T06:00:46.352607Z","shell.execute_reply.started":"2025-11-14T06:00:27.325565Z","shell.execute_reply":"2025-11-14T06:00:46.351933Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: compaction_demo\n\nUser > What is the latest news about AI in healthcare?\ngemini-2.5-flash-lite >  Here's a summary of the latest news and trends in AI in healthcare, focusing on recent developments and ongoing impactful areas:\n\n**Key Trends and Recent Developments:**\n\n*   **AI for Drug Discovery and Development:** This remains a major area of focus. Companies are increasingly using AI to:\n    *   **Identify new drug targets:** Analyzing vast biological datasets to pinpoint proteins or pathways involved in diseases.\n    *   **Design novel molecules:** Generating candidate drug compounds with desired properties.\n    *   **Predict drug efficacy and toxicity:** Speeding up the early stages of research and reducing costly failures.\n    *   **Optimize clinical trial design:** Identifying suitable patient populations and predicting trial outcomes.\n    *   **Recent examples:** Companies like Recursion Pharmaceuticals, Atomwise, and Insilico Medicine are making significant strides, with some drugs developed with AI now entering clinical trials.\n\n*   **AI in Medical Imaging:** AI continues to revolutionize how medical images are analyzed.\n    *   **Radiology:** AI algorithms are becoming highly adept at detecting subtle anomalies in X-rays, CT scans, MRIs, and mammograms, often matching or exceeding human accuracy for certain conditions (e.g., detecting lung nodules, diabetic retinopathy, breast cancer).\n    *   **Pathology:** AI is assisting pathologists in analyzing tissue samples, identifying cancerous cells, and grading tumors.\n    *   **Challenges:** Ensuring regulatory approval, addressing bias in datasets, and integrating AI tools seamlessly into existing workflows are ongoing challenges.\n\n*   **AI-Powered Diagnostics and Early Disease Detection:** Beyond imaging, AI is being used to analyze various data types for diagnosis.\n    *   **Genomics:** AI helps interpret complex genomic data to identify predispositions to diseases or guide personalized treatments.\n    *   **Wearable Devices & Remote Monitoring:** AI analyzes data from smartwatches, continuous glucose monitors, and other wearables to detect early signs of conditions like atrial fibrillation, sleep apnea, or changes in chronic disease status.\n    *   **Natural Language Processing (NLP):** AI is increasingly used to extract valuable information from unstructured clinical notes, patient histories, and research papers to aid in diagnosis and identify trends.\n\n*   **Personalized Medicine and Treatment Planning:** AI is crucial for tailoring treatments to individual patients.\n    *   **Oncology:** AI can analyze a patient's genetic makeup, tumor characteristics, and treatment history to recommend the most effective therapies, predict response rates, and monitor for recurrence.\n    *   **Predictive Analytics:** AI models can predict patient risk for developing certain conditions (e.g., sepsis, hospital readmission) allowing for proactive interventions.\n\n*   **AI in Clinical Operations and Administration:**\n    *   **Workflow Optimization:** AI is streamlining administrative tasks, such as scheduling appointments, managing billing, and reducing physician burnout by automating documentation.\n    *   **Resource Allocation:** Predicting patient flow and demand to optimize hospital staffing and resource utilization.\n\n*   **Generative AI and Large Language Models (LLMs) in Healthcare:** This is a rapidly evolving area.\n    *   **Medical Documentation:** LLMs can help draft clinical notes, summarize patient encounters, and generate discharge instructions.\n    *   **Medical Education and Training:** LLMs can act as tutors, answer medical questions, and generate realistic case scenarios for training.\n    *   **Patient Engagement:** AI-powered chatbots are being developed to answer patient questions, provide health information, and offer basic triage.\n    *   **Ethical and safety concerns:** Ensuring the accuracy, privacy, and security of LLM-generated medical information is paramount. Rigorous validation and human oversight are essential.\n\n**Challenges and Considerations:**\n\n*   **Data Privacy and Security:** Protecting sensitive patient data is critical.\n*   **Regulatory Hurdles:** Gaining approval from bodies like the FDA for AI-powered medical devices and software is complex.\n*   **Bias in AI:** AI models trained on biased datasets can perpetuate or even amplify health disparities. Ensuring fairness and equity is a major focus.\n*   **Integration into Workflows:** Seamlessly integrating AI tools into existing healthcare systems and clinical practices is essential for adoption.\n*   **Trust and Adoption:** Building trust among healthcare professionals and patients in AI's capabilities is ongoing.\n*   **Cost and Accessibility:** Ensuring that AI-driven healthcare solutions are affordable and accessible to all populations.\n\n**Overall Outlook:**\n\nThe integration of AI into healthcare is accelerating. While challenges remain, the potential for AI to improve diagnostics, accelerate drug discovery, personalize treatments, and enhance operational efficiency is immense. Expect continued innovation and increased adoption of AI solutions across the entire healthcare ecosystem.\n\nTo get the *very latest* news, I'd recommend checking reputable sources like:\n\n*   **Medical Journals:** *Nature Medicine*, *The Lancet*, *JAMA*, *NEJM*.\n*   **Healthcare Technology News Sites:** FierceBiotech, MedTech Dive, STAT News, MobiHealthNews.\n*   **Major Tech Company Blogs:** Google Health, Microsoft Healthcare, IBM Research.\n*   **Conferences and Industry Reports:** HIMSS, HLTH, and reports from consulting firms specializing in healthcare.\n\n ### Session: compaction_demo\n\nUser > Are there any new developments in drug discovery?\ngemini-2.5-flash-lite >  Yes, there are constant and exciting new developments in drug discovery, particularly with the increasing integration of AI and advanced technologies. Here are some of the most significant and recent trends:\n\n**1. AI and Machine Learning Dominating Early-Stage Discovery:**\n\n*   **Target Identification:** AI is rapidly accelerating the identification of novel drug targets. Instead of relying solely on traditional hypotheses, AI can sift through massive datasets (genomics, proteomics, transcriptomics, electronic health records) to uncover previously unknown disease-related pathways and molecules.\n    *   **Example:** Companies like **Recursion Pharmaceuticals** and **Insitro** are using AI to build large-scale biological datasets and identify drug targets with unprecedented speed.\n*   **Molecule Design and Optimization:** Generative AI models are now capable of designing novel drug-like molecules from scratch, or optimizing existing ones for better efficacy, reduced toxicity, and improved pharmacokinetic properties.\n    *   **Example:** **Atomwise** uses deep learning to predict how small molecules will bind to target proteins, speeding up the screening process. **Exscientia** has been at the forefront of using AI to design novel drug candidates that have entered clinical trials.\n*   **Predicting Drug Properties:** AI is getting better at predicting how a drug will behave in the body (absorption, distribution, metabolism, excretion - ADME) and its potential toxicity, reducing the number of compounds that fail later in development.\n\n**2. Novel Modalities Beyond Small Molecules and Antibodies:**\n\n*   **RNA Therapeutics:** While mRNA vaccines gained prominence, the potential of RNA therapeutics for a wider range of diseases is being explored. AI is helping to design more stable and effective RNA molecules, and identify optimal delivery methods.\n    *   **Companies:** **Moderna**, **BioNTech**, and **Alnylam Pharmaceuticals** are key players.\n*   **Peptide Therapeutics:** Peptides are showing promise as they can be more specific than small molecules and easier to manufacture than antibodies. AI is being used to design novel peptide sequences with therapeutic potential.\n*   **Gene Editing (CRISPR and beyond):** Advances in gene editing are moving towards therapeutic applications for genetic diseases. While still in early stages for many conditions, the potential is enormous.\n    *   **Companies:** **CRISPR Therapeutics**, **Intellia Therapeutics**, and **Editas Medicine**.\n*   **Targeted Protein Degradation (TPD):** This emerging approach aims to remove disease-causing proteins from cells rather than just inhibiting them. AI is crucial for identifying the right \"tags\" to attach to proteins for degradation.\n    *   **Companies:** **Arvinas** and **Nurix Therapeutics** are leading this space.\n\n**3. Advanced Preclinical and Clinical Trial Innovations:**\n\n*   **Organoids and \"Organ-on-a-Chip\" Technologies:** These sophisticated in-vitro models more closely mimic human physiology, providing better preclinical data and reducing reliance on animal testing. AI can help analyze the complex data generated by these systems.\n*   **Digital Twins:** Creating virtual replicas of patients or specific organs to simulate drug responses and optimize treatment plans before they are administered in real life.\n*   **AI in Clinical Trial Design and Recruitment:** AI is being used to identify optimal patient populations, predict trial success rates, and even recruit participants more efficiently by analyzing electronic health records.\n\n**4. Increased Collaboration and Open Innovation:**\n\n*   **Pharma-AI Partnerships:** Major pharmaceutical companies are actively partnering with or acquiring AI-driven biotech startups to leverage their expertise and technology.\n*   **Data Sharing Initiatives:** While still challenging due to privacy concerns, there's a growing recognition of the need for data sharing and collaborative platforms to accelerate discovery.\n\n**Examples of Recent Successes/Milestones:**\n\n*   **First AI-designed drug to enter Phase 3 trials:** Companies like **Exscientia** have achieved this significant milestone, demonstrating the real-world impact of AI in accelerating the drug development pipeline.\n*   **New drug approvals leveraging AI in some stage of their development:** While not always explicitly marketed, AI has played a role in the discovery or optimization of several recently approved drugs.\n\n**Key Challenges Remain:**\n\n*   **Data Quality and Standardization:** The effectiveness of AI is highly dependent on the quality and consistency of the data it's trained on.\n*   **Translational Validity:** Ensuring that discoveries made in silico or in preclinical models accurately translate to human efficacy and safety.\n*   **Regulatory Scrutiny:** Regulators are still developing frameworks for evaluating AI-driven drug discovery and development.\n*   **Cost and Complexity:** Implementing advanced AI and novel technology platforms can be expensive.\n\nIn summary, drug discovery is in a transformative period, with AI and new technological approaches drastically speeding up the process, expanding the types of therapeutic targets and modalities, and ultimately aiming to bring life-saving treatments to patients faster and more efficiently.\n\n ### Session: compaction_demo\n\nUser > Tell me more about the second development you found.\ngemini-2.5-flash-lite >  You're referring to **Novel Modalities Beyond Small Molecules and Antibodies** in drug discovery. This is a crucial area because it's about expanding the \"toolbox\" available to drug developers, moving beyond the traditional pillars of small molecules and protein-based drugs (like antibodies).\n\nLet's break down the key \"novel modalities\" and why they are significant:\n\n**1. RNA Therapeutics:**\n\n*   **What they are:** These therapies use RNA molecules to influence gene expression. Instead of directly interacting with a protein, they can instruct cells to produce more of a beneficial protein, less of a harmful one, or even to target specific RNA molecules for degradation.\n    *   **mRNA (messenger RNA):** Carries the genetic code for a protein. As seen with COVID-19 vaccines, mRNA can be delivered into cells, telling them to produce a specific protein (like a viral spike protein to train the immune system). In a therapeutic context, it could instruct cells to produce a missing or deficient protein (e.g., for genetic disorders).\n    *   **siRNA (small interfering RNA) & shRNA (short hairpin RNA):** These molecules can silence specific genes by targeting and degrading their mRNA transcripts. This is useful for diseases where a particular protein is overproduced or causing harm.\n    *   **Antisense Oligonucleotides (ASOs):** These are short, synthetic strands of DNA or RNA that can bind to specific mRNA sequences, either blocking translation into protein or altering splicing patterns of the mRNA.\n    *   **MicroRNAs (miRNAs):** Naturally occurring RNA molecules that regulate gene expression, and can be mimicked or inhibited therapeutically.\n\n*   **Why they are significant:**\n    *   **Precision:** Can target specific genes or gene products with high accuracy.\n    *   **Versatility:** Potential applications for a wide range of diseases, including genetic disorders, viral infections, cancer, and cardiovascular diseases.\n    *   **Speed:** Once a target gene is identified, designing an RNA therapeutic can sometimes be faster than developing a traditional small molecule or antibody.\n    *   **Addressing \"Undruggable\" Targets:** Many disease-causing proteins are difficult to target with traditional drugs. RNA therapies offer new ways to tackle these challenges.\n\n*   **Recent Developments:**\n    *   The success of mRNA COVID-19 vaccines has significantly boosted investment and research in mRNA technology for other applications.\n    *   Several siRNA and ASO drugs have already been approved for conditions like rare genetic diseases (e.g., spinal muscular atrophy, hereditary transthyretin amyloidosis).\n    *   Ongoing research into more efficient and targeted delivery systems is critical, as getting RNA into the right cells in the body remains a hurdle.\n\n**2. Peptide Therapeutics:**\n\n*   **What they are:** Peptides are short chains of amino acids, smaller than proteins. They are natural signaling molecules in the body and can be designed to mimic or block the action of endogenous peptides.\n\n*   **Why they are significant:**\n    *   **Specificity:** Peptides can be highly specific to their target receptors.\n    *   **Potency:** They can be very potent at low doses.\n    *   **Favorable Safety Profile:** Often have a better safety profile than small molecules or antibodies because they are derived from natural building blocks.\n    *   **Improved Manufacturing:** Generally easier and cheaper to manufacture compared to antibodies.\n\n*   **Recent Developments:**\n    *   **GLP-1 receptor agonists** (like semaglutide and liraglutide, used for diabetes and weight loss) are a prime example of successful peptide therapeutics.\n    *   Development of longer-acting peptides to reduce dosing frequency.\n    *   Exploration of peptides for cancer treatment, autoimmune diseases, and neurological disorders.\n    *   AI is playing a role in designing novel peptide sequences with enhanced stability and efficacy.\n\n**3. Gene Editing Technologies (e.g., CRISPR-Cas9):**\n\n*   **What they are:** Technologies that allow precise modification of DNA sequences within cells. This can involve correcting mutations that cause genetic diseases, inserting therapeutic genes, or disrupting genes that contribute to disease.\n\n*   **Why they are significant:**\n    *   **Curative Potential:** Offers the possibility of a one-time treatment that permanently corrects the underlying genetic defect, rather than just managing symptoms.\n    *   **Broad Applicability:** Potential for treating a vast array of monogenic disorders (diseases caused by a single gene defect).\n\n*   **Recent Developments:**\n    *   The first CRISPR-based gene editing therapy, **Casgevy**, was approved in the UK and US for sickle cell disease and beta-thalassemia, marking a historic moment.\n    *   Ongoing clinical trials for other genetic diseases like hereditary blindness and specific forms of cancer.\n    *   Challenges include delivery to the target cells (often ex vivo, where cells are removed, edited, and reinfused), off-target edits, and long-term safety.\n\n**4. Targeted Protein Degradation (TPD):**\n\n*   **What they are:** Instead of inhibiting a protein's function, TPD aims to eliminate the protein itself. It involves attaching a \"tag\" to a target protein that flags it for destruction by the cell's natural protein disposal machinery (the ubiquitin-proteasome system).\n    *   **PROTACs (Proteolysis Targeting Chimeras):** A prominent class of TPD molecules that bridge the target protein with an E3 ubiquitin ligase, marking the target protein for degradation.\n\n*   **Why they are significant:**\n    *   **\"Undruggable\" Targets:** Can target proteins that are not easily inhibited by traditional small molecules, especially those that lack an active site.\n    *   **Catalytic Mechanism:** A single TPD molecule can lead to the degradation of multiple protein molecules, making them potentially highly potent.\n    *   **Overcoming Resistance:** Can be effective against cancer cells that have developed resistance to existing therapies.\n\n*   **Recent Developments:**\n    *   Several TPD candidates are in clinical trials, particularly for oncology.\n    *   Research is expanding beyond PROTACs to other TPD technologies.\n    *   AI is assisting in identifying suitable E3 ligases and designing molecules that can effectively recruit them to target proteins.\n\nThese novel modalities represent a paradigm shift in how we approach drug discovery. They offer the potential to tackle diseases that were previously considered untreatable and to develop therapies with greater precision and durability. The rapid pace of innovation in these areas is a major driving force in modern biomedical research.\n\n ### Session: compaction_demo\n\nUser > Who are the main companies involved in that?\ngemini-2.5-flash-lite >  You're asking about the main companies involved in **Novel Modalities Beyond Small Molecules and Antibodies**. This is a rapidly evolving field, so the landscape is dynamic. Here's a breakdown of key players across the different modalities:\n\n**1. RNA Therapeutics:**\n\n*   **mRNA Focus:**\n    *   **Moderna:** A leader in mRNA technology, known for its COVID-19 vaccine, now developing mRNA therapeutics for infectious diseases, cancer, and rare genetic disorders.\n    *   **BioNTech:** Partnered with Pfizer for the COVID-19 vaccine, also has a robust pipeline of mRNA-based cancer immunotherapies and vaccines.\n    *   **CureVac:** Another significant player in mRNA technology, developing vaccines and protein-based therapeutics.\n\n*   **siRNA & ASO Focus:**\n    *   **Alnylam Pharmaceuticals:** A pioneer and leader in siRNA therapeutics, with several approved drugs for rare genetic diseases (e.g., Onpattro, Givlaari, Oxlumo).\n    *   **Ionis Pharmaceuticals:** A major force in ASO therapeutics, with approved drugs for spinal muscular atrophy (Spinraza) and other conditions.\n    *   **Arrowhead Pharmaceuticals:** Developing RNAi (RNA interference) therapies for a range of liver diseases and other conditions.\n    *   **Dicerna Pharmaceuticals (now Novo Nordisk):** Focuses on RNAi therapeutics, particularly for liver diseases.\n\n**2. Peptide Therapeutics:**\n\n*   **Large Pharma (often through acquisitions or partnerships):** Many large pharmaceutical companies are heavily invested in peptide therapeutics, especially for metabolic diseases and oncology.\n    *   **Novo Nordisk:** A dominant player in diabetes and obesity with its GLP-1 receptor agonists (semaglutide - Ozempic, Wegovy; liraglutide - Victoza, Saxenda).\n    *   **Eli Lilly and Company:** Another major player in diabetes and obesity with GLP-1 receptor agonists (tirzepatide - Mounjaro, Zepbound) and other peptide-based drugs.\n    *   **Sanofi:** Developing peptide-based therapies for diabetes, cardiovascular diseases, and other areas.\n\n*   **Specialized Biotech Companies:**\n    *   **Peptide-focused companies:** Many smaller biotechs are dedicated solely to peptide discovery and development, often using AI and advanced design platforms. (Specific names can vary as the field grows).\n\n**3. Gene Editing Technologies (e.g., CRISPR):**\n\n*   **Pioneering Biotech Companies:**\n    *   **CRISPR Therapeutics:** A leading company in CRISPR-based gene therapies, notably for blood disorders. They partnered with Vertex Pharmaceuticals for the approved Casgevy.\n    *   **Intellia Therapeutics:** Developing in vivo (directly in the body) CRISPR-based therapies for genetic diseases, including transthyretin amyloidosis.\n    *   **Editas Medicine:** Focused on developing CRISPR-based therapies for ocular diseases and other genetic disorders.\n\n*   **Large Pharma Involvement (often through partnerships):**\n    *   **Vertex Pharmaceuticals:** Partnered with CRISPR Therapeutics for the development and commercialization of Casgevy.\n    *   **Gilead Sciences:** Investing heavily in gene editing research and development.\n\n**4. Targeted Protein Degradation (TPD):**\n\n*   **Leading Biotech Innovators:**\n    *   **Arvinas:** A pioneer in developing PROTACs, with drug candidates in clinical trials for breast cancer, prostate cancer, and other solid tumors.\n    *   **Nurix Therapeutics:** Developing both small molecule E3 ligase modulators and protein degraders for oncology and immune disorders.\n    *   **Kymera Therapeutics:** Also developing protein degraders for a range of diseases, including cancer and autoimmune conditions.\n\n*   **Large Pharma Interest (partnerships and internal R&D):**\n    *   Many major pharmaceutical companies are actively partnering with TPD companies or building their own internal TPD discovery platforms.\n    *   **Pfizer, Novartis, Merck, Bristol Myers Squibb, Sanofi,** and others are all engaged in TPD research.\n\n**Important Considerations:**\n\n*   **Partnerships & Acquisitions:** The lines between these companies are often blurred. Large pharmaceutical companies frequently partner with or acquire smaller biotech firms that have pioneered these novel modalities.\n*   **AI's Role:** As mentioned, Artificial Intelligence is becoming an indispensable tool for *all* of these modalities, helping with target identification, molecule design, prediction, and optimization.\n*   **Platform Technologies:** Many of these companies are building \"platforms\" ‚Äì not just developing one drug, but a technology that can be applied to discover and develop many different drugs across various diseases.\n\nThis list isn't exhaustive, as new companies are constantly emerging and established ones are expanding their focus. However, it highlights the major players driving innovation in these exciting new frontiers of drug discovery.\n","output_type":"stream"}],"execution_count":15},{"cell_type":"markdown","source":"### 4.3 Verifying Compaction in the Session History\n\nThe conversation above looks normal, but the history has been changed behind the scenes. How can we prove it?\n\nWe can inspect the `events` list from our session. The compaction process **doesn't delete old events; it replaces them with a single, new `Event` that contains the summary.** Let's find it.","metadata":{}},{"cell_type":"code","source":"# Get the final session state\nfinal_session = await session_service.get_session(\n    app_name=research_runner_compacting.app_name,\n    user_id=USER_ID,\n    session_id=\"compaction_demo\",\n)\n\nprint(\"--- Searching for Compaction Summary Event ---\")\nfound_summary = False\nfor event in final_session.events:\n    # Compaction events have a 'compaction' attribute\n    if event.actions and event.actions.compaction:\n        print(\"\\n‚úÖ SUCCESS! Found the Compaction Event:\")\n        print(f\"  Author: {event.author}\")\n        print(f\"\\n Compacted information: {event}\")\n        found_summary = True\n        break\n\nif not found_summary:\n    print(\n        \"\\n‚ùå No compaction event found. Try increasing the number of turns in the demo.\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T06:06:56.707445Z","iopub.execute_input":"2025-11-14T06:06:56.707816Z","iopub.status.idle":"2025-11-14T06:06:56.718803Z","shell.execute_reply.started":"2025-11-14T06:06:56.707790Z","shell.execute_reply":"2025-11-14T06:06:56.718202Z"}},"outputs":[{"name":"stdout","text":"--- Searching for Compaction Summary Event ---\n\n‚úÖ SUCCESS! Found the Compaction Event:\n  Author: user\n\n Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='ff23a150-00d1-43b1-bde5-5e0451d5497f' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763100027.353988, 'end_timestamp': 1763100036.559324, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The user asked for the latest news on AI in healthcare, to which the AI agent provided a comprehensive overview covering drug discovery, medical imaging, diagnostics, personalized medicine, clinical operations, and generative AI.\\n\\nFollowing up on drug discovery, the user inquired about specific new developments. The AI agent then detailed several key trends:\\n\\n1.  **AI and Machine Learning in Early-Stage Discovery:** Highlighting AI\\'s role in target identification, molecule design, and property prediction.\\n2.  **Novel Modalities Beyond Small Molecules and Antibodies:** This was the development the user asked to know more about.\\n3.  **Advanced Preclinical and Clinical Trial Innovations:** Including organoids, digital twins, and AI in trial design.\\n4.  **Increased Collaboration and Open Innovation:** Emphasizing partnerships between pharma and AI companies.\\n\\nThe AI agent then elaborated on the **Novel Modalities** category, explaining:\\n\\n*   **RNA Therapeutics:** Including mRNA, siRNA, ASOs, and their potential for treating various diseases.\\n*   **Peptide Therapeutics:** Their specificity, potency, and use in treatments like GLP-1 agonists.\\n*   **Gene Editing (CRISPR):** Its curative potential for genetic diseases, with the recent approval of Casgevy as a landmark achievement.\\n*   **Targeted Protein Degradation (TPD):** How it eliminates disease-causing proteins, its advantage for \"undruggable\" targets, and the development of PROTACs.\\n\\nThe conversation concluded with the AI agent emphasizing that these novel modalities are transforming drug discovery and expanding therapeutic possibilities. No questions or tasks remain unresolved.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='a0ecd418-ee6e-453f-bd1f-c62b71d063cc' timestamp=1763100043.618494\n","output_type":"stream"}],"execution_count":16},{"cell_type":"markdown","source":"### 4.4 What you've accomplished: Automatic Context Management\n\nYou just found the proof! The presence of that special summary `Event` in your session's history is the tangible result of the compaction process.\n\n**Let's recap what you just witnessed:**\n\n1.  **Silent Operation**: You ran a standard conversation, and from the outside, nothing seemed different.\n2.  **Background Compaction**: Because you configured the `App` with `EventsCompactionConfig`, the ADK `Runner` automatically monitored the conversation length. Once the threshold was met, it triggered the summarization process in the background.\n3.  **Verified Result**: By inspecting the session's events, you found the summary that the LLM generated. This summary now replaces the older, more verbose turns in the agent's active context.\n\n**For all future turns in this conversation, the agent will be given this concise summary instead of the full history.** This saves costs, improves performance, and helps the agent stay focused on what's most important.\n","metadata":{}},{"cell_type":"markdown","source":"### 4.5 More Context Engineering options in ADK\n\n#### üëâ Custom Compaction\nIn this example, we used ADK's default summarizer. For more advanced use cases, you can provide your own by defining a custom `SlidingWindowCompactor` and passing it to the config. This allows you to control the summarization prompt or even use a different, specialized LLM for the task. You can read more about it in the [official documentation](https://google.github.io/adk-docs/context/compaction/).\n\n#### üëâ Context Caching\nADK also provides **Context Caching** to help reduce the token size of the static instructions that are fed to the LLM by caching the request data. Read more about it [here](https://google.github.io/adk-docs/context/caching/).","metadata":{}},{"cell_type":"markdown","source":"### The Problem\n\nWhile we can do Context Compaction and use a database to resume a session, we face new challenges now. In some cases, **we have key information or preferences that we want to share across other sessions.** \n\nIn these scenarios, instead of sharing the entire session history, transferring information from a few key variables can improve the session experience. Let's see how to do it!","metadata":{}},{"cell_type":"markdown","source":"---\n## ü§ù Section 5: Working with Session State\n\n### 5.1 Creating custom tools for Session state management\n\nLet's explore how to manually manage session state through custom tools. In this example, we'll identify a **transferable characteristic**, like a user's name and their country, and create tools to capture and save it.\n\n**Why This Example?**\n\nThe username is a perfect example of information that:\n\n- Is introduced once but referenced multiple times\n- Should persist throughout a conversation\n- Represents a user-specific characteristic that enhances personalization\n\nHere, for demo purposes, we'll create two tools that can store and retrieve user name and country from the Session State. **Note that all tools have access to the `ToolContext` object.** You don't have to create separate tools for each piece of information you want to share. ","metadata":{}},{"cell_type":"code","source":"# Define scope levels for state keys (following best practices)\nUSER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n\n\n# This demonstrates how tools can write to session state using tool_context.\n# The 'user:' prefix indicates this is user-specific data.\ndef save_userinfo(\n    tool_context: ToolContext, user_name: str, country: str\n) -> Dict[str, Any]:\n    \"\"\"\n    Tool to record and save user name and country in session state.\n\n    Args:\n        user_name: The username to store in session state\n        country: The name of the user's country\n    \"\"\"\n    # Write to session state using the 'user:' prefix for user data\n    tool_context.state[\"user:name\"] = user_name\n    tool_context.state[\"user:country\"] = country\n\n    return {\"status\": \"success\"}\n\n\n# This demonstrates how tools can read from session state.\ndef retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n    \"\"\"\n    Tool to retrieve user name and country from session state.\n    \"\"\"\n    # Read from session state\n    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n    country = tool_context.state.get(\"user:country\", \"Country not found\")\n\n    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n\n\nprint(\"‚úÖ Tools created.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T06:14:01.013046Z","iopub.execute_input":"2025-11-14T06:14:01.013367Z","iopub.status.idle":"2025-11-14T06:14:01.020760Z","shell.execute_reply.started":"2025-11-14T06:14:01.013346Z","shell.execute_reply":"2025-11-14T06:14:01.019841Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Tools created.\n","output_type":"stream"}],"execution_count":17},{"cell_type":"markdown","source":"**Key Concepts:**\n- Tools can access `tool_context.state` to read/write session state\n- Use descriptive key prefixes (`user:`, `app:`, `temp:`) for organization\n- State persists across conversation turns within the same session","metadata":{}},{"cell_type":"markdown","source":"### 5.2 Creating an Agent with Session State Tools\n\nNow let's create a new agent that has access to our session state management tools:","metadata":{}},{"cell_type":"code","source":"# Configuration\nAPP_NAME = \"default\"\nUSER_ID = \"default\"\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n# Create an agent with session state tools\nroot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"\"\"A text chatbot.\n    Tools for managing user context:\n    * To record username and country when provided use `save_userinfo` tool. \n    * To fetch username and country when required use `retrieve_userinfo` tool.\n    \"\"\",\n    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n)\n\n# Set up session service and runner\nsession_service = InMemorySessionService()\nrunner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n\nprint(\"‚úÖ Agent with session state tools initialized!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T06:15:48.916449Z","iopub.execute_input":"2025-11-14T06:15:48.917165Z","iopub.status.idle":"2025-11-14T06:15:48.923987Z","shell.execute_reply.started":"2025-11-14T06:15:48.917136Z","shell.execute_reply":"2025-11-14T06:15:48.922994Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Agent with session state tools initialized!\n","output_type":"stream"}],"execution_count":18},{"cell_type":"markdown","source":"### 5.3 Testing Session State in Action\n\nLet's test how the agent uses session state to remember information across conversation turns:","metadata":{}},{"cell_type":"code","source":"# Test conversation demonstrating session state\nawait run_session(\n    runner,\n    [\n        \"Hi there, how are you doing today? What is my name?\",  # Agent shouldn't know the name yet\n        \"My name is Sam. I'm from Poland.\",  # Provide name - agent should save it\n        \"What is my name? Which country am I from?\",  # Agent should recall from session state\n    ],\n    \"state-demo-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T06:16:06.275356Z","iopub.execute_input":"2025-11-14T06:16:06.275675Z","iopub.status.idle":"2025-11-14T06:16:09.243835Z","shell.execute_reply.started":"2025-11-14T06:16:06.275654Z","shell.execute_reply":"2025-11-14T06:16:09.243037Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: state-demo-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing great. I'd love to tell you your name, but I don't have that information stored yet. Can you please tell me what it is? Also, where are you from?\n\nUser > My name is Sam. I'm from Poland.\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  It is a pleasure to meet you, Sam! I have saved your information and will remember that you are from Poland.\n\nUser > What is my name? Which country am I from?\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  Your name is Sam and you are from Poland.\n","output_type":"stream"}],"execution_count":19},{"cell_type":"markdown","source":"### 5.4 Inspecting Session State\n\nLet's directly inspect the session state to see what's stored:","metadata":{}},{"cell_type":"code","source":"# Retrieve the session and inspect its state\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n)\n\nprint(\"Session State Contents:\")\nprint(session.state)\nprint(\"\\nüîç Notice the 'user:name' and 'user:country' keys storing our data!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T06:16:37.705662Z","iopub.execute_input":"2025-11-14T06:16:37.706274Z","iopub.status.idle":"2025-11-14T06:16:37.712170Z","shell.execute_reply.started":"2025-11-14T06:16:37.706249Z","shell.execute_reply":"2025-11-14T06:16:37.711204Z"}},"outputs":[{"name":"stdout","text":"Session State Contents:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n\nüîç Notice the 'user:name' and 'user:country' keys storing our data!\n","output_type":"stream"}],"execution_count":20},{"cell_type":"markdown","source":"### 5.5 Session State Isolation\n\nAs we've already seen, an important characteristic of session state is that it's isolated per session. Let's demonstrate this by starting a new session:","metadata":{}},{"cell_type":"code","source":"# Start a completely new session - the agent won't know our name\nawait run_session(\n    runner,\n    [\"Hi there, how are you doing today? What is my name?\"],\n    \"new-isolated-session\",\n)\n\n# Expected: The agent won't know the name because this is a different session","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T06:17:17.113041Z","iopub.execute_input":"2025-11-14T06:17:17.113339Z","iopub.status.idle":"2025-11-14T06:17:17.800446Z","shell.execute_reply.started":"2025-11-14T06:17:17.113319Z","shell.execute_reply":"2025-11-14T06:17:17.799578Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: new-isolated-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing well, thank you for asking. I can't recall your name at the moment. Could you please tell me what it is?\n","output_type":"stream"}],"execution_count":21},{"cell_type":"markdown","source":"### 5.6 Cross-Session State Sharing\n\nWhile sessions are isolated by default, you might notice something interesting. Let's check the state of our new session (`new-isolated-session`):","metadata":{}},{"cell_type":"code","source":"# Check the state of the new session\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n)\n\nprint(\"New Session State:\")\nprint(session.state)\n\n# Note: Depending on implementation, you might see shared state here.\n# This is where the distinction between session-specific and user-specific state becomes important.","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T06:18:10.463048Z","iopub.execute_input":"2025-11-14T06:18:10.463643Z","iopub.status.idle":"2025-11-14T06:18:10.468426Z","shell.execute_reply.started":"2025-11-14T06:18:10.463620Z","shell.execute_reply":"2025-11-14T06:18:10.467503Z"}},"outputs":[{"name":"stdout","text":"New Session State:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n","output_type":"stream"}],"execution_count":22},{"cell_type":"markdown","source":"---\n\n## üßπ Cleanup","metadata":{}},{"cell_type":"code","source":"# Clean up any existing database to start fresh (if Notebook is restarted)\nimport os\n\nif os.path.exists(\"my_agent_data.db\"):\n    os.remove(\"my_agent_data.db\")\nprint(\"‚úÖ Cleaned up old database files\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-14T06:19:23.911754Z","iopub.execute_input":"2025-11-14T06:19:23.912104Z","iopub.status.idle":"2025-11-14T06:19:23.917422Z","shell.execute_reply.started":"2025-11-14T06:19:23.912081Z","shell.execute_reply":"2025-11-14T06:19:23.916463Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Cleaned up old database files\n","output_type":"stream"}],"execution_count":23},{"cell_type":"markdown","source":"---\n## üìä Summary\n\nüéâ Congratulations! You've learned the fundamentals of building stateful AI agents:\n\n- ‚úÖ **Context Engineering** - You understand how to assemble context for LLMs using Context Compaction\n- ‚úÖ **Sessions & Events** - You can maintain conversation history across multiple turns\n- ‚úÖ **Persistent Storage** - You know how to make conversations survive restarts\n- ‚úÖ **Session State** - You can track structured data during conversations\n- ‚úÖ **Manual State Management** - You've experienced both the power and limitations of manual approaches\n- ‚úÖ **Production Considerations** - You're ready to handle real-world challenges\n","metadata":{}},{"cell_type":"markdown","source":"---\n\n## ‚úÖ Congratulations! You did it üéâ\n\n**‚ÑπÔ∏è Note: No submission required!**\n\nThis notebook is for your hands-on practice and learning only. You **do not** need to submit it anywhere to complete the course.\n\n### üìö Learn More\n\nRefer to the following documentation to learn more:\n\n- [ADK Documentation](https://google.github.io/adk-docs/)\n- [ADK Sessions](https://google.github.io/adk-docs/)\n- [ADK Session-State](https://medium.com/google-cloud/2-minute-adk-manage-context-efficiently-with-artifacts-6fcc6683d274)\n- [ADK Session Compaction](https://google.github.io/adk-docs/context/compaction/#define-compactor)\n\n### üéØ Next Steps - Long Term Memory Systems (Part 2)\n\n#### Why do we need memory?\nIn this notebook, we manually identified a couple characteristic (username and country) and built tools to manage it. But real conversations involve hundreds of such characteristics:\n- User preferences and habits\n- Past interactions and their outcomes\n- Domain knowledge and expertise levels\n- Communication styles and patterns\n- Contextual relationships between topics\n\n**The Memory System in ADK automates this entire process**, making it a valuable asset for building truly Context-Aware Agents that can accommodate any user's current and future needs.\n\nIn the next notebook (Part 2: Memory Management), you'll learn how to:\n- Enable automatic memory extraction from conversations\n- Build agents that learn and adapt over time\n- Create truly personalized experiences at scale\n- Manage long-term knowledge across sessions\n\nReady to transform your manual state management into an intelligent, automated Memory system? Let's continue to Part 2!","metadata":{}},{"cell_type":"markdown","source":"---\n\n| Authors |\n| --- |\n| [Sampath M](https://www.linkedin.com/in/msampathkumar/) |","metadata":{}}]}